| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accumulation of anthracenyl-amino acid topoisomerase I and II inhibitors in drug-sensitive and drug-resistant human ovarian cancer cell lines determined by high-performance liquid chromatography
|
Cummings, J.
|
|
1995
|
37 |
1-2 |
p. 103-109
|
artikel
|
| 2 |
A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal caner
|
Moore, M. J.
|
|
1995
|
37 |
1-2 |
p. 86-90
|
artikel
|
| 3 |
An open study to assess the safety, tolerance and pharmacokinetics of an intravenous infusion of granisetron given at 3 mg over 30 s in patients receiving chemotherapy for malignant disease
|
Carmichael, James
|
|
1995
|
37 |
1-2 |
p. 134-138
|
artikel
|
| 4 |
Antimicrotubule effects of the novel antitumor benzoylphenylurea derivative HO-221
|
Ando, N.
|
|
1995
|
37 |
1-2 |
p. 63-69
|
artikel
|
| 5 |
A phase I and pharmacokinetics study of prolonged ambulatory-infusion carboplatin
|
Olver, Ian N.
|
|
1995
|
37 |
1-2 |
p. 79-85
|
artikel
|
| 6 |
A phase I trial of 5-day continuous infusion cisplatin and interferon α
|
Gosland, Michael P.
|
|
1995
|
37 |
1-2 |
p. 39-46
|
artikel
|
| 7 |
Collateral sensitivity to radiation and CIS-platinum in a multidrug-resistant human leukemia cell line
|
Cho, Jonathan
|
|
1995
|
37 |
1-2 |
p. 168-172
|
artikel
|
| 8 |
Dosing of ThioTEPA for myeloablative therapy
|
Przepiorka, D.
|
|
1995
|
37 |
1-2 |
p. 155-160
|
artikel
|
| 9 |
Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy
|
Sommadossi, J.-P.
|
|
1995
|
37 |
1-2 |
p. 14-22
|
artikel
|
| 10 |
Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities
|
Barberi-Heyob, M.
|
|
1995
|
37 |
1-2 |
p. 110-116
|
artikel
|
| 11 |
Functional expression of the renal organic cation transporter and P-glycoprotein in Xenopus laevis oocytes
|
Nelson, J. A.
|
|
1995
|
37 |
1-2 |
p. 187-189
|
artikel
|
| 12 |
Intraperitoneal 5-fluoro-2′-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study
|
Israel, Valerie K.
|
|
1995
|
37 |
1-2 |
p. 32-38
|
artikel
|
| 13 |
In vitro effect of r-verapamil on acute myelogenous leukemia blast cells: studies of cytokine secretion and cytokine-dependent blast proliferation
|
Bruserud, Øystein
|
|
1995
|
37 |
1-2 |
p. 70-78
|
artikel
|
| 14 |
Long-term pharmacokinetic behavior of platinum after cisplatin administration
|
Gamelin, E.
|
|
1995
|
37 |
1-2 |
p. 97-102
|
artikel
|
| 15 |
Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids
|
Hüsken, Birgitta C. P.
|
|
1995
|
37 |
1-2 |
p. 55-62
|
artikel
|
| 16 |
Morphonuclear characterization of drug resistance by means of digital cell-image analysis: an in vitro assessment
|
Pauwels, Olivier
|
|
1995
|
37 |
1-2 |
p. 179-186
|
artikel
|
| 17 |
Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R )-4,5-bis(aminomethyl)-2-isopropyl- 1, 3-dioxolane]platinum(II), as determined by ex vivo pharmacodynamics
|
Kim, D.-K.
|
|
1995
|
37 |
1-2 |
p. 1-6
|
artikel
|
| 18 |
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer
|
Millward, M. J.
|
|
1995
|
37 |
1-2 |
p. 161-167
|
artikel
|
| 19 |
Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts
|
Johnsson, A.
|
|
1995
|
37 |
1-2 |
p. 23-31
|
artikel
|
| 20 |
Pharmacokinetics of 4′-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer
|
Mader, R. M.
|
|
1995
|
37 |
1-2 |
p. 91-96
|
artikel
|
| 21 |
Pharmacological attempts to improve the bioavailability of oral etoposide
|
Joel, S. P.
|
|
1995
|
37 |
1-2 |
p. 125-133
|
artikel
|
| 22 |
Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics
|
Conley, B. A.
|
|
1995
|
37 |
1-2 |
p. 139-149
|
artikel
|
| 23 |
Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation
|
Launay-Iliadis, M. C.
|
|
1995
|
37 |
1-2 |
p. 47-54
|
artikel
|
| 24 |
Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation
|
Los, G.
|
|
1995
|
37 |
1-2 |
p. 150-154
|
artikel
|
| 25 |
Stability of the i.v. and oral formulations of etoposide in solution
|
Joel, S. P.
|
|
1995
|
37 |
1-2 |
p. 117-124
|
artikel
|
Tijdschrift beschrijving